MetLife Investment Management LLC Purchases Shares of 6,667 Cartesian Therapeutics, Inc. (NASDAQ:RNAC)
MetLife Investment Management LLC purchased a new position in Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 6,667 shares of the company’s stock, valued at approximately $119,000. Other institutional investors and hedge funds have also made changes to their positions in the company. Charles Schwab Investment […]
MetLife Investment Management LLC purchased a new position in Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 6,667 shares of the company’s stock, valued at approximately $119,000. Other institutional investors and hedge funds have also made changes to their positions in the company. Charles Schwab Investment […]
